MACROGENICS, INC. Increase (Decrease) in Restricted Cash for Operating Activities
MACROGENICS, INC. (MGNX) reported Increase (Decrease) in Restricted Cash for Operating Activities of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2018-02-27
- MACROGENICS, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2015-12-31 was $0.00.
- MACROGENICS, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2014-12-31 was $0.00.
- MACROGENICS, INC. increase (decrease) in restricted cash for operating activities for fiscal 2017 was $0.00.
- MACROGENICS, INC. increase (decrease) in restricted cash for operating activities for fiscal 2016 was $0.00.
- MACROGENICS, INC. increase (decrease) in restricted cash for operating activities for fiscal 2015 was -$300.00K.
- MACROGENICS, INC. increase (decrease) in restricted cash for operating activities for fiscal 2014 was -$105.00K.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 3 month | Increase (Decrease) in Restricted Cash for Operating Activities 9 month | Increase (Decrease) in Restricted Cash for Operating Activities 12 month | Increase (Decrease) in Restricted Cash for Operating Activities 12 month as first filed |
|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-27 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-02-27 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$300.00K 10-K · filed 2018-02-27 | ||
| 2015-09-30 | -$300.00K 10-Q · filed 2015-11-04 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$105.00K 10-K · filed 2017-02-28 | ||
| 2014-09-30 | -$105.00K 10-Q · filed 2015-11-04 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 | |||
| 2012-12-31 | -$177.00K 10-K · filed 2015-03-03 | -$177.32K 10-K · filed 2014-03-20 | ||
| 2011-12-31 | $513.00 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |